Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilsartan + amlodipine vs azilsartan or amlodipine in primary hypertension
CTR20233472Phase 3Completed
- Sponsor
- Jiangxi Shimei Pharmaceutical
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azilsartan medoxomil + amlodipine in essential hypertension, sponsored by Jiangxi Shimei Pharmaceutical. Started Nov 2023; status: completed.
02
Drugs
azilsartan medoxomil + amlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20233472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233472.